Question 73

Shingrix given subcutaneously instead of IM should be reported to MedWatch.

Reporting the administration of Shingrix subcutaneously instead of intramuscularly is necessary to MedWatch, which is the FDA's reporting system for adverse events and medication errors.

A) OSHA

OSHA (Occupational Safety and Health Administration) focuses on ensuring workplace safety and health regulations. It does not handle medication errors or adverse drug reactions, making it an incorrect choice for reporting issues related to vaccine administration.

B) iPLEDGE

iPLEDGE is a risk management program aimed at preventing fetal exposure to isotretinoin and is not relevant to vaccine administration or reporting errors related to it. Therefore, this option is also incorrect.

C) MedWatch

MedWatch is the FDA's program for reporting adverse events and medication errors, including improper administration routes for vaccines. Reporting to MedWatch is essential to ensure proper tracking and response to these incidents, making it the correct choice.

D) ISMP VERP

ISMP VERP (Institute for Safe Medication Practices Vaccine Error Reporting Program) is specifically focused on vaccine errors, but it is not the primary reporting agency for all types of adverse events, making it less appropriate than MedWatch for this particular situation.

Conclusion

MedWatch is the most appropriate channel for reporting the administration of Shingrix subcutaneously instead of intramuscularly, as it addresses adverse events and medication errors. Other options, such as OSHA and iPLEDGE, are unrelated to vaccine reporting, while ISMP VERP, although relevant, does not replace the necessity of reporting to MedWatch for comprehensive oversight.